Terms: = Uterine cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF
32 results:
1. DOCK1 regulates the malignant biological behavior of endometrial cancer through c-raf/ERK pathway.
Xie S; Jin Y; Wang J; Li J; Peng M; Zhu X
BMC Cancer; 2024 Mar; 24(1):296. PubMed ID: 38438882
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations.
Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA SOX21-AS1 accelerates endometrial carcinoma progression through the miR-7-5p/raf1 pathway.
Sun M; Chen D; Chen Y; Wu Y
World J Surg Oncol; 2023 Jul; 21(1):217. PubMed ID: 37481582
[TBL] [Abstract] [Full Text] [Related]
5. SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/β-catenin and Raf/ERK1/2 signaling pathways.
Chen X; Sun Z; Zhou S; Jiang W; Li J; Song G; Zhu X
Mol Carcinog; 2023 Aug; 62(8):1147-1162. PubMed ID: 37132991
[TBL] [Abstract] [Full Text] [Related]
6. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
Front Public Health; 2022; 10():979933. PubMed ID: 36203656
[TBL] [Abstract] [Full Text] [Related]
7. SEC61G Promotes Cervical cancer Proliferation by Activating MAPK Signaling Pathway.
Fan Y; Wang Y; Liu F; Wang H; Li Q
Dis Markers; 2022; 2022():7016079. PubMed ID: 36092956
[TBL] [Abstract] [Full Text] [Related]
8. Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway.
Takao T; Masuda H; Kajitani T; Miki F; Miyazaki K; Yoshimasa Y; Katakura S; Tomisato S; Uchida S; Uchida H; Tanaka M; Maruyama T
Stem Cell Res Ther; 2022 Jun; 13(1):225. PubMed ID: 35659728
[TBL] [Abstract] [Full Text] [Related]
9. MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer.
Wu Y; Huang J; Ivan C; Sun Y; Ma S; Mangala LS; Fellman BM; Urbauer DL; Jennings NB; Ram P; Coleman RL; Hu W; Sood AK
Gynecol Oncol; 2021 Oct; 163(1):181-190. PubMed ID: 34391578
[TBL] [Abstract] [Full Text] [Related]
10. Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study.
Coleman RL; Hu W; Soliman P; Nick A; Ramirez PT; Westin SN; Garcia ME; Zhu Z; Palancia J; Fellman BM; Yuan Y; Ram P; Bischoff F; Schmeler K; Bodurka D; Meyer LA; Sood AK
Gynecol Oncol; 2021 Apr; 161(1):104-112. PubMed ID: 33551196
[TBL] [Abstract] [Full Text] [Related]
11. RCE‑4, a potential anti‑cervical cancer drug isolated from Reineckia carnea, induces autophagy via the dual blockade of PI3K and ERK pathways in cervical cancer CaSki cells.
Xiang W; Zhang RJ; Jin GL; Tian L; Cheng F; Wang JZ; Xing XF; Xi W; Tang SJ; Chen JF
Int J Mol Med; 2020 Jan; 45(1):245-254. PubMed ID: 31746346
[TBL] [Abstract] [Full Text] [Related]
12. CircAGFG1 promotes cervical cancer progression via miR-370-3p/raf1 signaling.
Wu F; Zhou J
BMC Cancer; 2019 Nov; 19(1):1067. PubMed ID: 31703640
[TBL] [Abstract] [Full Text] [Related]
13. Mapping Transient Protein Interactions at the Nanoscale in Living Mammalian Cells.
De Keersmaecker H; Camacho R; Rantasa DM; Fron E; Uji-I H; Mizuno H; Rocha S
ACS Nano; 2018 Oct; 12(10):9842-9854. PubMed ID: 30192513
[TBL] [Abstract] [Full Text] [Related]
14. Oncomirs Expression Profiling in uterine Leiomyosarcoma Cells.
de Almeida BC; Garcia N; Maffazioli G; dos Anjos LG; Baracat EC; Carvalho KC
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295562
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-497 accelerates apoptosis while inhibiting proliferation, migration, and invasion through negative regulation of the MAPK/ERK signaling pathway via raf-1.
Tao L; Zhang CY; Guo L; Li X; Han NN; Zhou Q; Liu ZL
J Cell Physiol; 2018 Oct; 233(10):6578-6588. PubMed ID: 29150931
[TBL] [Abstract] [Full Text] [Related]
16. Bag-1L is a stress-withstand molecule prevents the downregulation of Mcl-1 and c-raf under control of heat shock proteins in cisplatin treated HeLa cervix cancer cells.
Ozfiliz P; Arisan ED; Coker-Gurkan A; Obakan P; Eralp TN; Dinler-Doganay G; Palavan-Unsal N
Asian Pac J Cancer Prev; 2014; 15(11):4475-82. PubMed ID: 24969872
[TBL] [Abstract] [Full Text] [Related]
17. Correlation of cervical smear and pathohistological findings.
Asotic A; Taric S; Asotic J
Med Arch; 2014; 68(2):106-9. PubMed ID: 24937933
[TBL] [Abstract] [Full Text] [Related]
18. Cross-talk between EphA2 and BRaf/craf is a key determinant of response to Dasatinib.
Huang J; Hu W; Bottsford-Miller J; Liu T; Han HD; Zand B; Pradeep S; Roh JW; Thanapprapasr D; Dalton HJ; Pecot CV; Rupaimoole R; Lu C; Fellman B; Urbauer D; Kang Y; Jennings NB; Huang L; Deavers MT; Broaddus R; Coleman RL; Sood AK
Clin Cancer Res; 2014 Apr; 20(7):1846-55. PubMed ID: 24486585
[TBL] [Abstract] [Full Text] [Related]
19. Anti-proliferative and pro-apoptotic effects of 3,3'-diindolylmethane in human cervical cancer cells.
Zhu J; Li Y; Guan C; Chen Z
Oncol Rep; 2012 Sep; 28(3):1063-8. PubMed ID: 22736073
[TBL] [Abstract] [Full Text] [Related]
20. Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane.
Chiu CF; Ho MY; Peng JM; Hung SW; Lee WH; Liang CM; Liang SM
Oncogene; 2013 Feb; 32(6):777-87. PubMed ID: 22410782
[TBL] [Abstract] [Full Text] [Related]
[Next]
